10-day hyperlipidemic clamp in cats: Effects on insulin sensitivity, inflammation, and glucose metabolism-related genes

Hormone and Metabolic Research

Volumn 42, Issue 5, 2010, Pages 340-347

  Zini, E ^a   Osto, M ^a   Konrad, D ^b   Franchini, M ^a   Sieber Ruckstuhl, N S ^a   Kaufmann, K ^a   Guscetti, F ^a   Ackermann, M ^a   Lutz, T A ^a   Reusch, C E ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Adiponectin; Feline; Inflammation; Lipid infusion

Indexed keywords

ADIPONECTIN; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOVENOES; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OROSOMUCOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; SODIUM CHLORIDE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; CONTROL GROUP; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; GLUCOSE METABOLISM; HISTOPATHOLOGY; HYPERLIPIDEMIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID STORAGE; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

ADIPOSE TISSUE; ANIMALS; BACTEREMIA; BLOOD GLUCOSE; BLOTTING, WESTERN; CATS; DNA PRIMERS; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORTER TYPE 4; HYPERLIPIDEMIAS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LIVER; MALE; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRIGLYCERIDES;

FELIDAE;

EID: 77951997865     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1248251     Document Type: Article

References (42)

1. Lutz TA, Rand JS. Pathogenesis of feline diabetes mellitus. Vet Clin North Am Small Anim Pract 1995 25 527-552
2. Cefalu WT. Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition. ILAR J 2006 47 186-198
3. Henson MS, OBrien TD. Feline models of type 2 diabetes mellitus. ILAR J 2006 47 234-242 (Pubitemid 43986032)
4. McGarry JD. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002 51 7-18
5. Greenfield JR, Campbell LV. Relationship between inflammation, insulin resistance and type 2 diabetes: cause or effect? Curr Diabetes Rev 2006 2 195-211 (Pubitemid 44082940)
6. Fabris R, Nisoli E, Lombardi AM, Tonello C, Serra R, Granzotto M, Cusin I, Rohner-Jeanrenaud F, Federspil G, Carruba MO, Vettor R. Preferential channeling of energy fuels toward fat rather than muscle during high free fatty acid availability in rats. Diabetes 2001 50 601-608 (Pubitemid 32195225)
7. Park E, Wong V, Guan X, Oprescu AI, Giacca A. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo. J Endocrinol 2007 195 323-331 (Pubitemid 350143112)
8. Lavoie F, Frisch F, Brassard P, Normand-Lauzire F, Cyr D, Gagnon R, Drouin R, Baillargeon JP, Carpentier AC. Relationship between total and high molecular weight adiponectin levels and plasma nonesterified fatty acid tolerance during enhanced intravascular triacylglycerol lipolysis in men. J Clin Endocrinol Metab 2009 94 998-1004
9. Meshkani R, Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clin Biochem 2009 42 1331-1346
10. Xiao C, Giacca A, Lewis GF. Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men. Diabetologia 2008 51 139-146 (Pubitemid 50003768)
11. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006 116 3015-3025 (Pubitemid 44684486)
12. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005 115 1111-1119
13. Semple RK, Chatterjee VK, ORahilly S. PPAR gamma and human metabolic disease. J Clin Invest 2006 116 581-589 (Pubitemid 43326862)
14. Fabris R, Nisoli E, Lombardi AM, Tonello C, Serra R, Granzotto M, Cusin I, Rohner-Jeanrenaud F, Federspil G, Carruba MO, Vettor R. Preferential channeling of energy fuels toward fat rather than muscle during high free fatty acid availability in rats. Diabetes 2001 50 601-608 (Pubitemid 32195225)
15. Reusch CE, Haberer B. Evaluation of fructosamine in dogs and cats with hypo- or hyperproteinaemia, azotaemia, hyperlipidaemia and hyperbilirubinaemia. Vet Rec 2001 148 370-376 (Pubitemid 33613563)
16. Han P, Zhang YY, Lu Y, He B, Zhang W, Xia F. Effects of different free fatty acids on insulin resistance in rats. Hepatobiliary Pancreat Dis Int 2008 7 91-96 (Pubitemid 351247064)
17. Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, Defronzo RA, Cusi K. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 2005 54 1640-1648 (Pubitemid 40770753)
18. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996 97 2859-2865 (Pubitemid 26197099)
19. Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Fürnsinn C, Moser E, Waldhusl W. Rapid impairment of skeletal muscle glucose transport/ phosphorylation by free fatty acids in humans. Diabetes 1999 48 358-364 (Pubitemid 29061111)
20. Zini E, Osto M, Franchini M, Guscetti F, Donath MY, Perren A, Heller RS, Linscheid P, Bouwman M, Ackermann M, Lutz TA, Reusch CE. Hyperglycaemia but not hyperlipidaemia causes beta cell dysfunction and beta cell loss in the domestic cat. Diabetologia 2009 52 336-346
21. Appleton DJ, Rand JS, Sunvold GD. Basal plasma insulin and homeostasis model assessment (HOMA) are indicators of insulin sensitivity in cats. J Feline Med Surg 2005 7 183-193
22. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999 22 1462-1470 (Pubitemid 29418240)
23. Zini E, Linscheid P, Franchini M, Kaufmann K, Monnais E, Kutter AP, Ackermann M, Lutz TA, Reusch CE. Partial sequencing and expression of genes involved in glucose metabolism in adipose tissues and skeletal muscle of healthy cats. Vet J 2009 180 66-70
24. Kipar A, Leutenegger CM, Hetzel U, Akens MK, Mislin CN, Reinacher M, Lutz H. Cytokine mRNA levels in isolated feline monocytes. Vet Immunol Immunopathol 2001 78 305-315 (Pubitemid 32243948)
25. Lane DJ. 16S/23S rRNA sequencing. In: Stackebrandt E and Goodfellow M (ed). Nucleic acids techniques in bacterial systematics. Chichester, United Kingdom John Wiley & Sons 1991 115-147
26. Storgaard H, Jensen CB, Bjrnholm M, Song XM, Madsbad S, Zierath JR, Vaag AA. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes. J Clin Endocrinol Metab 2004 89 1301-1311 (Pubitemid 38368429)
27. Salomaa V, Ahola I, Tuomilehto J, Aro A, Pietinen P, Korhonen HJ, Penttil I. Fatty acid composition of serum cholesterol esters in different degrees of glucose intolerance: a population-based study. Metabolism 1990 39 1285-1291
28. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 1993 328 238-244 (Pubitemid 23035309)
29. Vessby B, Tengblad S, Lithell H. Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 1994 37 1044-1050 (Pubitemid 24300462)
30. Lovejoy JC, Smith SR, Champagne CM, Most MM, Lefevre M, DeLany JP, Denkins YM, Rood JC, Veldhuis J, Bray GA. Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care 2002 25 1283-1288 (Pubitemid 41071133)
31. Noto A, Zahradka P, Yurkova N, Xie X, Truong H, Nitschmann E, Ogborn MR, Taylor CG. Dietary conjugated linoleic acid decreases adipocyte size and favorably modifies adipokine status and insulin sensitivity in obese, insulin-resistant rats. Metabolism 2007 56 1601-1611 (Pubitemid 350060927)
32. Ceron JJ, Eckersall PD, Martnez-Subiela S. Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Pathol 2005 34 85-99
33. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007 92 1023-1033 (Pubitemid 46465679)
34. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000 43 1498-1506 (Pubitemid 32734855)
35. Wueest S, Rapold RA, Rytka JM, Schoenle EJ, Konrad D. Basal lipolysis, not the degree of insulin resistance, differentiates large from small isolated adipocytes in high-fat fed mice. Diabetologia 2009 52 541-546
36. Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE. Increased hepatic and circulating interleukin-6 levels in human non-alcoholic steatohepatitis. Am J Gastroenterol 2008 103 1372-1379 (Pubitemid 351813900)
37. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006 29 1357-1362 (Pubitemid 44125935)
38. Hoenig M, Thomaseth K, Waldron M, Ferguson DC. Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss. Am J Physiol Regul Integr Comp Physiol 2007 292 R227-R234 (Pubitemid 46089834)
39. Trevaskis JL, Gawronska-Kozak B, Sutton GM, McNeil M, Stephens JM, Smith SR, Butler AA. Role of adiponectin and inflammation in insulin resistance of Mc3r and Mc4r knockout mice. Obesity 2007 15 2664-2672
40. Ajuwon KM, Spurlock ME. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes. Am J Physiol Regul Integr Comp Physiol 2005 288 R1220-R1225
41. Combs TP, Pajvani UB, Berg AH, Lin Y, Jelicks LA, Laplante M, Nawrocki AR, Rajala MW, Parlow AF, Cheeseboro L, Ding YY, Russell RG, Lindemann D, Hartley A, Baker GR, Obici S, Deshaies Y, Ludgate M, Rossetti L, Scherer PE. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 2004 145 367-383 (Pubitemid 38094532)
42. Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 2003 52 1355-1363 (Pubitemid 36666188)